By Josh Beckerman
Autonomix Medical shares fell to their lowest point yet after the medical device company reported the pricing of a $9 million public offering.
The stock was recently down 53% to $6.31, with an intraday low of $5.85. Adjusted for an October reverse stock split, the company's January initial public offering priced at $100.
The company said Friday that the offering is comprised of 1.38 million common stock units, or pre-funded warrant units in lieu of common stock units, priced at $6.54 per common stock unit or $6.539 per pre-funded warrant unit. The units each have one share or pre-funded warrant plus one Series A warrant.
On Nov. 1, Autonomix filed to offer up to 698,812 common stock units.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
November 22, 2024 13:26 ET (18:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。